Viyash Scientific Issues Clarification on Director Resignation Date Error

1 min read     Updated on 31 Mar 2026, 06:34 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Viyash Scientific Limited has issued a regulatory clarification addressing a date error in their previous intimation about director resignations. The company corrected an inadvertent mistake where the covering letter mentioned March 30, 2025 instead of the correct date March 30, 2026 for the resignation of Non-Executive Directors Dr. Fabian Kausche and Mr. Gregory Andrews.

powered bylight_fuzz_icon
36462808

*this image is generated using AI for illustrative purposes only.

Viyash Scientific Limited has issued a clarification regarding a date error in its previous intimation about the resignation of two Non-Executive Directors. The company, formerly known as Sequent Scientific Limited, submitted the clarification to BSE and NSE on March 31, 2026, addressing an inadvertent mistake in the covering letter of their earlier filing.

Date Error Clarification

The company acknowledged that in their March 30, 2026 intimation regarding director resignations, the covering letter incorrectly mentioned the date as March 30, 2025 instead of the correct date of March 30, 2026. This clarification was necessary to ensure accurate regulatory compliance and avoid any confusion among stakeholders.

Clarification Details: Information
Original Filing Date: March 30, 2026
Incorrect Date Mentioned: March 30, 2025
Correct Date: March 30, 2026
Clarification Filed: March 31, 2026

Director Resignations Confirmed

The resignations of both Non-Executive Directors remain effective as originally announced. Dr. Fabian Kausche (DIN: 08976500) and Mr. Gregory Andrews (DIN: 08904518) stepped down from their positions on March 30, 2026, citing personal reasons and other commitments.

Director Details: Information
Dr. Fabian Kausche: DIN: 08976500, Non-Executive Director
Mr. Gregory Andrews: DIN: 08904518, Non-Executive Director
Effective Date: March 30, 2026
Reason: Personal reasons and other commitments

Regulatory Compliance

The clarification was filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary & Compliance Officer Yoshita Vora signed the clarification document, expressing regret for any inconvenience caused by the date error. The company requested stock exchanges to take note of the correction and maintain accurate records.

Company Background

Both directors had expressed gratitude for their opportunity to serve on the board during their tenure. Dr. Fabian Kausche, based in Duluth, Georgia, USA, and Mr. Gregory Andrews both wished the company continued success and growth. The company has completed all necessary formalities related to these board changes in compliance with applicable regulations and has informed the Registrar of Companies and other regulatory authorities as required by law.

Historical Stock Returns for Viyash Scientific

1 Day5 Days1 Month6 Months1 Year5 Years
-0.61%-1.01%-10.01%-1.61%+41.20%-21.38%

How will the departure of two Non-Executive Directors impact Viyash Scientific's board composition and governance structure?

What timeline has the company established for appointing replacement Non-Executive Directors to fill these vacant positions?

Could these resignations signal broader strategic changes or restructuring plans within Viyash Scientific's operations?

Viyash Scientific Shareholders Approve Leadership Appointments and Stock Options Through Postal Ballot

2 min read     Updated on 13 Mar 2026, 07:41 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Viyash Scientific Limited shareholders approved four special resolutions through postal ballot with overwhelming majority support ranging from 97.32% to 98.83%. Key approvals included Dr. Haribabu Bodepudi's appointment as Managing Director and Group CEO, employee stock options grant exceeding 1% of issued capital, and appointments of Mr. Rajaram Narayanan and Mr. Srinivas Vasireddy as whole-time directors. The electronic voting process concluded on March 12, 2026, with participation from 1,33,361 shareholders on record date.

powered bylight_fuzz_icon
34956685

*this image is generated using AI for illustrative purposes only.

Viyash Scientific Limited has successfully concluded its postal ballot process, with shareholders approving four critical special resolutions related to key leadership appointments and employee stock options. The voting process, which ended on March 12, 2026, demonstrated strong shareholder confidence in the company's strategic direction.

Leadership Appointments Receive Strong Support

The postal ballot results revealed overwhelming shareholder approval across all proposed resolutions. The most significant appointment was Dr. Haribabu Bodepudi (DIN: 01119687) as Managing Director and Group CEO for a two-year term, which received 97.32% approval from voting shareholders.

Resolution Details Votes in Favour Votes Against Approval Rate
Dr. Haribabu Bodepudi as MD & CEO 31,78,56,683 87,40,557 97.32%
Employee Stock Options Grant 31,78,35,758 87,60,146 97.32%
Mr. Rajaram Narayanan as Whole-time Director 34,05,55,347 40,42,628 98.83%
Mr. Srinivas Vasireddy as Whole-time Director 34,16,98,683 46,99,267 98.64%

Comprehensive Voting Participation

The postal ballot process witnessed significant participation from the company's shareholder base. With 1,33,361 total shareholders on the record date of February 06, 2026, the voting was conducted entirely through electronic means via National Securities Depository Limited (NSDL) platform.

Shareholder Category Participation

The voting pattern showed strong support across different shareholder categories:

  • Promoter and Promoter Group: Achieved 100% participation with unanimous approval across all resolutions
  • Public Institutions: Demonstrated 74.52% voting participation with varying approval rates
  • Public Non-Institutions: Showed participation rates ranging from 19.87% to 36.02% with high approval percentages

Stock Options Authorization

Shareholders approved the grant of stock options exceeding 1% of the company's issued capital to an identified employee within one year. This resolution received 97.32% approval, indicating strong shareholder confidence in the company's talent retention and incentive strategies.

Regulatory Compliance and Process

The postal ballot was conducted in strict compliance with Section 110 of the Companies Act, 2013, and Rule 22 of the Companies (Management and Administration) Rules, 2014. Nishant Darak & Associates served as the scrutinizer for the voting process, ensuring transparency and fairness.

Timeline and Process Details

Process Milestone Date
Postal Ballot Notice Date February 05, 2026
Record Date February 06, 2026
Notice Dispatch February 10, 2026
E-voting Commencement February 11, 2026 (9:00 AM)
E-voting Conclusion March 12, 2026 (5:00 PM)
Results Declaration March 13, 2026

The company utilized electronic voting exclusively, following MCA Circular No. 14/2020 and subsequent amendments, which provided shareholders with a secure and efficient voting mechanism. All resolutions are deemed passed as of March 12, 2026, the last date of remote e-voting, marking a significant milestone in the company's governance and leadership structure.

Historical Stock Returns for Viyash Scientific

1 Day5 Days1 Month6 Months1 Year5 Years
-0.61%-1.01%-10.01%-1.61%+41.20%-21.38%

More News on Viyash Scientific

1 Year Returns:+41.20%